Cytophage Technologies Balance Sheet Health
Financial Health criteria checks 6/6
Cytophage Technologies has a total shareholder equity of CA$6.5M and total debt of CA$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are CA$8.7M and CA$2.2M respectively.
Key information
0%
Debt to equity ratio
CA$0
Debt
Interest coverage ratio | n/a |
Cash | CA$5.58m |
Equity | CA$6.50m |
Total liabilities | CA$2.24m |
Total assets | CA$8.74m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: CYTO's short term assets (CA$6.2M) exceed its short term liabilities (CA$851.3K).
Long Term Liabilities: CYTO's short term assets (CA$6.2M) exceed its long term liabilities (CA$1.4M).
Debt to Equity History and Analysis
Debt Level: CYTO is debt free.
Reducing Debt: CYTO had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: CYTO has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: CYTO has sufficient cash runway for 1.1 years if free cash flow continues to reduce at historical rates of 12% each year.